COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 2724: Articles 27231-27240  | Next

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
Gonzalez-Cao, M., Antonazas-Basa, M., Puertolas, T., Munoz-Couselo, E., Manzano, J. L., Carrera, C., Marquez-Rodas, I., Lopez-Criado, P., Rodriguez-Moreno, J. F., Garcia-Castano, A., Martin-Liberal, J., Rodriguez-Jimenez, P., Puig, S., Cerezuela, P., Feito-Rodriguez, M., Rubio-Viqueira, B., Crespo, G., Luna-Fra, P., Aguayo, C., Ayala de Miguel, P., Feltes, R., Valles, L., Drozdowskyj, A., Soria, A., Maldonado, C., Fernandez-Morales, L., Rosell, R., Provencio, M., Berrocal, A.
10.1101/2020.05.19.20106971 — Posted: 2020-05-21
Dreaming during the Covid-19 pandemic: Computational assessment of dream reports reveals mental suffering associated with negative feelings and contagion fear
Mota, N. B., Weissheimer, J., Ribeiro, M., De Paiva, M., D'Avila, J., Simabucuru, G., Chaves, M. F., Cecchi, L., Cirne, J., Cecchi, G., Rodrigues, C., Copelli, M., Ribeiro, S.
10.1101/2020.05.19.20107078 — Posted: 2020-05-21
Analyzing the impact of SARS CoV-2 on the human proteome
Estrada, E.
10.1101/2020.05.21.107912 — Posted: 2020-05-21
Computational Analysis of Dynamic Allostery and Control in the SARS-CoV-2 Main Protease
McLeish, T. C., Dubanevics, I.
10.1101/2020.05.21.105965 — Posted: 2020-05-21
Modeling and Simulation of a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein in a Viral Membrane
Woo, H., Park, S.-J., Choi, Y. K., Park, T., Tanveer, M., Cao, Y., Kern, N. R., Lee, J., Yeom, M. S., Croll, T., Seok, C., Im, W.
10.1101/2020.05.20.103325 — Posted: 2020-05-21
Mechanistic insights into ventricular arrhythmogenesis of hydroxychloroquine and azithromycin for the treatment of COVID-19
Wang, G., Tian, X., Lu, C.-J., Flores, H., Maj, P., Zhang, K., Niu, Y., Wang, L., Du, Y., Ji, X., Xu, Y., Trafford, A., Li, D., Herring, N., Paterson, D., Huang, C., Zhang, H., Lei, M., Lei, G.
10.1101/2020.05.21.108605 — Posted: 2020-05-21
Unfractionated heparin potently inhibits the binding of SARS-CoV-2 spike protein to a human cell line
Partridge, L. J., Green, L. R., Monk, P. N.
10.1101/2020.05.21.107870 — Posted: 2020-05-21
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
Zang, J., Gu, C., Zhou, B., Zhang, C., Yang, Y., Xu, S., Zhang, X., Zhou, Y., Bai, L., Wu, Y., Sun, Z., Zhang, R., Deng, Q., Yuan, Z., Tang, H., Qu, D., Lavillette, D., Xie, Y., Huang, Z.
10.1101/2020.05.21.107565 — Posted: 2020-05-21
Rapid Isothermal Amplification and Portable Detection System for SARS-CoV-2
Ganguli, A., Mostafa, A., Berger, J., Aydin, M., Sun, F., Valera, E., Cunningham, B. T., King, W. P., Bashir, R.
10.1101/2020.05.21.108381 — Posted: 2020-05-21
Reverse Pneumatic Artificial Muscles for Application in Low-Cost Artificial Respirators
Mirvakili, S., Sim, D., Langer, R.
10.1101/2020.05.20.107342 — Posted: 2020-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).